Telmisartan Tablets
Failed Stability Specifications: Out of specification for blend uniformity.
Most common reason: Wrong potency / content (5 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Telmisartan. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Failed Stability Specifications: Out of specification for blend uniformity.
Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .
Defective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .
Superpotent; Hydrochlorothiazide
Subpotent Drug
Labeling: Label-mixup
Failed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer)
Failed Impurities/Degradation Specifications; 18 month long term stability study.
Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.
Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.
Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.
Presence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone within the tablet.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.